Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Northwestern Memorial Hospital studying arthritis drug’s potential in fighting cancer

01.07.2003


A research study under way at Northwestern Memorial Hospital is trying to find out if the popular anti-inflammatory drug Celebrex might do more than ease arthritis pain. Researchers at Northwestern Memorial are enrolling patients with early stage head and neck cancers or non-small cell lung cancers in a research study to see if Celebrex reduces the return of old tumors or the chance of getting a new cancer when taken after surgery or radiation treatments.



The double-blind, randomized study will enroll about 120 patients at Northwestern Memorial, the primary teaching hospital of Northwestern University’s Feinberg School of Medicine. Celebrex belongs to a class of drugs called COX-2 inhibitors that block the production of an enzyme called cyclooxygenese–2 or simply COX-2. COX-2 triggers pain and inflammation in arthritis sufferers and may also fuel the growth of cancer.

"COX-2 inhibitors have emerged in recent years as a promising anticancer therapy. Many cancers have high levels of COX-2," explains Athanassios Argiris, M.D., an oncologist at Northwestern Memorial Hospital. Dr. Argiris, who coordinates the clinical research in lung as well as head and neck cancer at the Robert H. Lurie Comprehensive Cancer Center, is the principal investigator of the research study, which is also expected to open in other major institutions in the U.S. in the coming months. COX-2 may promote the growth of new blood vessels that nourish the cancer tumors. "Taking Celebrex may starve the tumor of nutrients in a process called anti-angiogenesis," he says. "It also appears to promote self-destruction of cancer cells."


Based on successful clinical trials, Celebrex has been FDA-approved to treat those with a genetic syndrome, called familial adenomatous polyposis (FAP), a disorder that greatly increases the risk of colon cancer. Researchers expect that Celebrex may have similar positive effects for cancer treatment and prevention of other cancers.

Several clinical trials are under way to look at COX-2 inhibitors and their ability to prevent and treat a variety of cancers. "As far as I know, this is the only current study of its kind for head and neck cancer," says Dr. Argiris. "I’m expecting that COX-2 inhibitors, such as Celebrex, may slow tumor growth or shrink existing tumors in people with head and neck and lung cancers. Moreover, COX-2 inhibitors may act early in the cancer process and prevent formation of new tumors," says Dr. Argiris. "Celebrex is considered to be safer on the stomach than aspirin, so the reduced gastrointestinal side effects make this an especially exciting therapy," says Dr. Argiris.


###
For more information on this study, call Northwestern Memorial’s physician referral line at 877-926-4664.

About Northwestern Memorial Hospital

Northwestern Memorial Hospital (NMH) is one of the country’s premier academic medical centers and is the primary teaching hospital of Northwestern University’s Feinberg School of Medicine. Northwestern Memorial and its Prentice Women’s Hospital have 720 beds and more than 1,200 affiliated physicians and 5,000 employees. Providing care in a state-of-the-art facility, the hospital is recognized for its outstanding clinical and surgical advancements in such areas as cardiothoracic and vascular care, gastroenterology, neurology and neurosurgery, oncology, organ and bone marrow transplantation, and women’s health.

Northwestern Memorial was ranked as the nation’s 5th best hospital by the 2002 Consumer Checkbook survey of the nation’s physicians and is listed in the majority of specialties in this year’s US News & World Report’s issue of "America’s Best Hospitals." NMH is also cited as one of the "100 Best Companies for Working Mothers" by Working Mother magazine and has been chosen by Chicagoans year after year as their "most preferred hospital" in National Research Corporation’s annual survey.

Amanda Widtfeldt | EurekAlert!
Further information:
http://www.nmh.org/

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>